Luke Twelves, M.D., vice president of Medical for Lindus Health, shared his prediction for the year.
The GLP-1 [glucagon-like peptide 1] agents are poised to become viable options for treating indications beyond type 2 diabetes and obesity. Recent breakthroughs in research for sleep apnea, polycystic ovarian syndrome, Parkinson’s disease and more have demonstrated their potential.
Twelves
In the coming year, patients will have greater access to these medications than ever before. We’ll see more and more providers integrating GLP-1s into their patients’ treatment plans, indications across various therapeutic areas, and, subsequently, more payers offering coverage for them.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
FDA Approves First Drug for Excess Hunger in Prader-Willi Syndrome
March 27th 2025Vykat XR will be available in April to treat the intense hunger that is a hallmark of the rare genetic disease Prader-Willi syndrome. The price is based on a patient’s weight, and the average patient in the clinical trials would have had an average annual cost of $466,200 for the first year.
Read More
Medicare Costs Rise in 2025 With Higher Part D Premiums, Advantage Deductibles
March 27th 2025During last year’s enrollment period, millions of Medicare beneficiaries reviewed their coverage options and selected new Medicare plans for the 2025 calendar year due to changes including the plans being offered, increases in premiums and more, according to an eHealth analysis.
Read More